Lumeon wins MedTech Breakthrough Award - Gilde Healthcare

Lumeon wins MedTech Breakthrough Award

7. Juni 2017

LONDON AND NEW YORK – Lumeon, a leading digital health company, has won the MedTech Breakthrough Award for Best Overall Health Administration Software. The awards recognize the top companies, people, platforms and products in the global health and medical technology market today.

Lumeon’s Care Pathway Management (CPM) platform, that allows providers to automate and orchestrate workflows across the care continuum, impressed the judges with its capability to digitize risk reducing strategies, improve efficiency and scale best practice.

Robbie Hughes, Lumeon’s CEO said, “Alternative payment models are prompting the industry to think differently about the way care is delivered and how we collaboratively manage risk to deliver better quality outcomes. Providers want better visibility into outcomes data across the care continuum, as well as innovative ways of engaging patients and managing healthcare administration. I’m delighted to accept this award as we continue to deliver solutions that are both personalized and scalable.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories. This year’s program attracted more than 2,000 nominations from over 10 different countries throughout the world. All nominations were evaluated by an independent panel of experts within the medical and health industry.

“We are pleased to recognize Lumeon among the MedTech Breakthrough Awards this year,” stated James Johnson, Managing Director at MedTech Breakthrough. “Health administration can be an extremely complex proposition for healthcare providers, taking focus away from the ultimate goal of improving patient care. By automating and simplifying health workflows with software such as Lumeon’s Care Pathway Management platform, we see tremendous benefits for healthcare providers and patients alike. Congratulations to the entire Lumeon team on their industry recognition.”

Gilde Healthcare company Moximed raises $40 Million to advance world’s first Implantable Shock Absorber for Knee Osteoarthritis

Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced $40 million in Series C equity and debt financing. The round was led...
16. August 2022

Gilde Healthcare company Nalu appoints Thomas West as new president and CEO

Nalu Medical, Inc. (“Nalu”), a private company focused on innovative and minimally invasive solutions for chronic neuropathic pain, announced that the Board of Directors has appointed Thomas “Tom” West as President and Chief Executive Officer....
19. Juli 2022

Gilde Healthcare bolsters its Private Equity team in Frankfurt office

Dutch sector specialist Gilde Healthcare announces two new hires to its private equity team in Germany, following the recent close of its new €518m lower mid-market fund Gilde Healthcare Private Equity IV. With the recruitment...
12. Juli 2022